Rapid Response
Do We Need Better Lipid Tools for Cardiovascular Risk Assessment?
Abstract
Cardiovascular diseases still represent the major cause of death in most developed countries and ultimately kill as many men as women.1 In the last decades, the management of a number of “traditional” risk factors (including obesity, diabetes, smoking, hypertension, and hypercholesterolemia) has led to a significant reduction in cardiovascular morbidity and mortality, but new tools for risk assessment are needed to develop more effective strategies for primary and secondary prevention.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.